TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders

Obesity

Volumn 23, Issue 11, 2015, Pages 2199-2206

  Hong, Chun Pyo ^a,b   Yun, Chang Ho ^a   Lee, Gil Woo ^b   Park, Areum ^b   Kim, You Me ^b   Jang, Myoung Ho ^a  

^a Institute for Basic Science   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GLUCOSE; INSULIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; MACROPHAGE; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH1 CELL; WEIGHT GAIN; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PANNICULITIS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; CYTOKINES; DIET, HIGH-FAT; GLUCOSE INTOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MACROPHAGES; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; PANNICULITIS; TOLL-LIKE RECEPTOR 9; WEIGHT GAIN;

EID: 84946496158     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21215     Document Type: Article

References (40)

1. Kanneganti TD, Dixit VD., Immunological complications of obesity. Nat Immunol 2012; 13: 707-712.
2. Olefsky JM, Glass CK., Macrophages, inflammation, and insulin resistance. Ann Rev Physiol 2010; 72: 219-246.
3. Lumeng CN, Bodzin JL, Saltiel AR., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Investig 2007; 117: 175-184.
4. Nishimura S, Manabe I, Nagasaki M, et al., CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
5. Liu J, Divoux A, Sun J, et al., Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009; 15: 940-945.
6. Wu D, Molofsky AB, Liang HE, et al., Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332: 243-247.
7. Winer DA, Winer S, Shen L, et al., B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011; 17: 610-617.
8. Talukdar S, Oh da Y, Bandyopadhyay G, et al., Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 2012; 18: 1407-1412.
9. Schipper HS, Rakhshandehroo M, van de Graaf SF, et al., Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Investig 2012; 122: 3343-3354.
10. Lynch L, Nowak M, Varghese B, et al., Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012; 37: 574-587.
11. Trinchieri G, Sher A., Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7: 179-190.
12. Vijay-Kumar M, Aitken JD, Carvalho FA, et al., Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328: 228-231.
13. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al., Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56: 1986-1998.
14. Himes RW, Smith CW., Tlr2 is critical for diet-induced metabolic syndrome in a murine model. FASEB J 2010; 24: 731-739.
15. Hemmi H, Takeuchi O, Kawai T, et al., A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
16. Tabeta K, Georgel P, Janssen E, et al., Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 2004; 101: 3516-3521.
17. Albiger B, Dahlberg S, Sandgren A, et al., Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol 2007; 9: 633-644.
18. Krieg AM., Antiinfective applications of toll-like receptor 9 agonists. Proc Am Thorac Soc 2007; 4: 289-294.
19. Gilliet M, Lande R., Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr Opin Immunol 2008; 20: 401-407.
20. Celhar T, Magalhaes R, Fairhurst AM., TLR7 and TLR9 in SLE: When sensing self goes wrong. Immunol Res 2012; 53: 58-77.
21. Rachmilewitz D, Katakura K, Karmeli F, et al., Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126: 520-528.
22. Musch E, Lutfi T, von Stein P, et al., Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity. Inflamm Bowel Dis 2013; 19: 283-292.
23. Kadowaki T, Yamauchi T, Kubota N, et al., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Investig 2006; 116: 1784-1792.
24. Kim D, Kim J, Yoon JH, et al., CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice. Diabetologia 2014; 57: 1456-1465.
25. Winer S, Chan Y, Paltser G, et al., Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921-929.
26. Osborn O, Olefsky JM., The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012; 18: 363-374.
27. Feuerer M, Herrero L, Cipolletta D, et al., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930-939.
28. Rocha VZ, Folco EJ, Sukhova G, et al., Interferon-gamma, a Th1 cytokine, regulates fat inflammation: A role for adaptive immunity in obesity. Circulation Res 2008; 103: 467-476.
29. Odegaard JI, Chawla A., Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013; 339: 172-177.
30. Hotamisligil GS, Erbay E., Nutrient sensing and inflammation in metabolic diseases. Nature Rev Immunol 2008; 8: 923-934.
31. Takeda K, Kaisho T, Akira S., Toll-like receptors. Ann Rev Immunol 2003; 21: 335-376.
32. Jin C, Henao-Mejia J, Flavell RA., Innate immune receptors: Key regulators of metabolic disease progression. Cell Metab 2013; 17: 873-882.
33. Cani PD, Amar J, Iglesias MA, et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
34. Shi H, Kokoeva MV, Inouye K, et al., TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Investig 2006; 116: 3015-3025.
35. Kim SJ, Choi Y, Choi YH, et al., Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. J Nutr Biochem 2012; 23: 113-122.
36. Strissel KJ, DeFuria J, Shaul ME, et al., T cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity 2010; 18: 1918-1925.
37. Beutler B., Innate immunity: An overview. Mol Immunol 2004; 40: 845 -8 59.
38. Rose WA, 2nd, Sakamoto K, Leifer CA., TLR9 is important for protection against intestinal damage and for intestinal repair. Sci Rep 2012; 2: 574.
39. Boonstra A, Rajsbaum R, Holman M, et al., Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol 2006; 177: 7551-7558.
40. Ubeda C, Lipuma L, Gobourne A, et al., Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J Exp Med 2012; 209: 1445-1456.